ABOUT USABOUT US

Nanjing Aureole Pharmaceutical Co.,Ltd

Established in October 12, 2017 in Nanjing City where is the ancient capital of six dynasties, Aureole, with a total registered investment capital of 100 million Chinese Yuan, is a high-tech enterprise specialized in R&D, manufacturing and sale of the sterilized inhalation product and eyedrops with an international development strategy. Our R&D specialists accouts for 30% of the total 120 employees and more than 86% employees owns the bachelor degree.

More
More

ProductsProducts

Eyedrops

H1901

An 8-methoxy fluoroquinolone antimicrobial with an extremely wide spectrum of activity. In vitro, it showed broad-spectrum antimicrobial activity against gram-positive, gram-negative, anaerobes, acid-fast and atypical microorganisms such as mycoplasma, chlamydia and Legionella. It is used for the

More

Inhalation

H1702

Promote the movement of bronchial mucosa cilia to expel sputum. Mainly used to alleviate chronic obstructive pulmonary disease caused by bronchial asthma spasm symptoms, and prevent and cure bronchial asthma.

More

Inhalation

H1701

Promote the movement of bronchial mucosa cilia to expel sputum. Mainly used to alleviate chronic obstructive pulmonary disease caused by bronchial asthma spasm symptoms, and prevent and cure bronchial asthma.

More

Inhalation

H1801

Used in the treatment for severe bronchial asthma (status asthmatics) as well as chronic bronchospasm that does not respond to conventional therapy. Listed in the National Essential Drug List with an board market prospects.

More
More

CDMOCDMO

  • Formulation Development

    We have strong capabilities to provide CRO and CMO to our customer in inhalation products ,eye drops products, solid preparations, injection products and health care products. Thanks to the first-rate BFS system and various advanced testing equipment, we could provide reverse engineering for initial reference, drug substance screening, and a turnkey service from laboratory process optimization to pilot production, especially for inhalation and eye drops product.
    More
  • Pharmaceutical Analysis

    Our labs are constructed in accordance with the GLP standard of China, Europe and America, and managed with the LIMS system which is an industry well-recognized laboratory information management system. We could provide GMP qualitative and quantitative analysis service and stability research on drug substance, excipients, package, and intermediates to our customer.
    More
  • Drug Registration

    Our product registration department could provide registration service for IND, NDA and ANDA in China, EU and USA, and consulting service in certain countries and regions.
    More
  • Single Dosage Sterilized Preparation Manufacturing

    Equipped with the first-rate Rommelag BFS system, We produce single dosage sterilized inhalation preparation and eyedrops developed by our own team. And we have capacities and capabilities to provide those kind CMO service to our customer. We warmly welcome your visit and negotiate.
    More
More

News & EventsNews

2021.02.02

Aureole's Salbutamol Sulfate Inhalation Solution Recieved CDE Reference Number

          The Salbutamol Sulfate Inhalation Solution (2.5ml:2.5mg ) and the Salbutamol Sulfate Inhalation Solution (2.5ml:5mg ), which researched and developed independently by Aureole and is the first product to register, receives the reference number issued by CDE on Nov

More